🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are delighted to host Victor Velculescu Victor Velculescu Johns Hopkins Kimmel Cancer Center as our first keynote speaker at the OxCODE Symposium Victor shared his work on cell-free DNA fragmentomics for early detection of a variety of cancers   #oxcode24

Continuing with tech: McCullagh Group Oxford Chemistry discusses metabolomics for early detection Sarah Blagden OxfordOncology & Eleni Adamopoulou Nuffield Department of Medicine describe their use of immunopeptidomics to discover vaccine targets to prevent BRCA-associated cancers #oxcode24

Next is a panel discussion on translating research for patient benefit, featuring: Hazel Beaver Oxford Cancer PPI Claire Brown Oxford Science Enterprises Anna Dowrick @oxprimarycare Victor Velculescu Johns Hopkins Kimmel Cancer Center Chaired by Ellie Barnes 🚵‍♀️ #oxcode24

Last before lunch, we hear lightning talks from: Lucy Denly Ludwig Cancer Dimitris Vavoulis OxfordOncology Yi-Jhih Huang OxfordOncology Lucy Goudswaard Bristol Cancer Learn more about their research at the poster session over lunch! #oxcode24

Kicking off our session on preventive cancer vaccines, Catriona Gilmour Hamilton Oxford Cancer and PPI rep Anna Fry share the lessons learned so far from PPI consultations on the research to use vaccines to prevent cancer #oxcode24

We hear from two recently funded Science and Innovation at Cancer Research UK preventive cancer vaccine projects: Nancy Zaarour Ahmed Lab Nuffield Dept of Women's & Reproductive Health on OvarianVax David Church Centre for Human Genetics on LynchVax #oxcode24

In our early detection technologies session, Fergus Gleeson shares the outputs from dartlunghealth in lung cancer screening and Michael Pavlides RDM Oxford describes a liver MRI project building on DeLIVER-HCC #oxcode24

In our final talk of day 1, we are honoured to hear from keynote Dame Molly Stevens Kavli Institute for Nanoscience Discovery, Oxford, who discusses an impressive array of new bioengineering approaches to treat and detect cancer #oxcode24

OxCODE Associate Director Sarah Blagden closes the first day and encourages further conversations over networking drinks Thanks to our sponsors Moderna and Veritie Diagnostics #oxcode24

Welcome back to the Oxford Centre for Cancer Early Detection and Prevention (OxCODE) symposium! Today we will hear the latest on early cancer biology, risk, diagnosing cancer with non-specific symptoms and a panel discussion on getting research funded. Stay tuned! #oxcode24

Day 2 of the OxCODE symposium begins with the early cancer biology session featuring: Asger Jacobsen MRC WIMM on pre-leukaemic clonal selection Simon Leedham Centre for Human Genetics on spatial biology to understand colorectal cancer development #oxcode24

We warmly welcome our keynote speaker in the early cancer biology session, Sam Janes Lungs for Living DoM_UCL, who gave a fascinating summary of his research on pre-invasive lung cancer progression #oxcode24

Switching gears to risk stratification, we hear from Ling Yang Oxford Population Health (OxPop) on chronic pathogen infections and the risk of cancer and Andres Tamm OxPrimaryCareSci on FIT for colorectal cancer risk stratification #oxcode24

Last before lunch, we hear lightning talks from James Chettle OxfordOncology Natalie Jooss MRC WIMM #oxcode24

How to get your research funded? We heard insights from our panel: Talisia Quallo @CRUKResearch Florence Theberge Medical Research Council Janette Rawlinson Oxford Cancer PPI Françoise Howe #oxcode Chaired by Sarah Blagden   #oxcode24

In our last session, we hear about diagnosing cancers with non-specific symptoms in OUH SCAN (Fergus Gleeson OxfordOncology & Claire Friedemann Smith OxPrimaryCareSci) and barriers to research participation (Julie-Ann Moreland OUH & Aduke Onofowokan) #oxcode24

We are privileged to have Dr Georgia Black Wolfson Institute of Population Health give the final keynote of the OxCODE symposium on the organisation of non-specific symptom cancer pathways #oxcode24

Wrapping up the event, OxCODE Associate Director Simon Leedham summarises OxCODE’s history and achievements Thanks to our sponsors Moderna and Veritie Diagnostics and all participants and attendees for a stimulating conference celebrating our 5 year anniversary! #oxcode24

"We now know that cancer does not come from nowhere." Prof Sarah Blagden, director of a new research collaboration between pharma giant GSK and the University of Oxford, tells #R4Today about the development of a new 'pre-cancer' vaccine that could target the disease earlier.

'This partnership represents a step forward in cancer research.' Professor Irene Tracey comments on the launch of a new £50million immuno-prevention collaboration between University of Oxford and GSK to advance novel cancer research. 👇 cancer.ox.ac.uk/news/oxford-an…